Endocrinology, Vol 133, 2187-2196, Copyright © 1993 by Endocrine Society

ARTICLES

Glucocorticoid-induced activation of latent transforming growth factor- beta by normal human osteoblast-like cells

MJ Oursler, BL Riggs and TC Spelsberg
Department of Biochemistry and Molecular Biology, Mayo Foundation, Rochester, Minnesota 55905.

Transforming growth factor-beta (TGF beta) is a multifunctional growth factor in bone that is secreted as a latent complex and must be activated in order to influence cellular activity. We have investigated the influence of dexamethasone (Dex; a potent glucocorticoid) on the secretion and activation of latent TGF beta by normal human osteoblast- like cells (hOBs). Dex had no significant effect on TGF beta mRNA or total protein production, but treatment with Dex resulted in a steroid dose-dependent activation of up to 90% of the TGF beta produced by the hOBs. Dex-treated hOBs activated multiple latent forms of TGF beta. Conditioned medium from Dex-treated hOBs retained the ability to activate latent TGF beta when incubated at 37 C in the absence of cells. Unlike other cell systems, Dex-induced hOB-mediated TGF beta activation did not involve binding to the mannose-6-phosphate receptor. However, the activation was prevented by treatment of hOB cells with microtubual disrupting agents, by the addition of protease inhibitors, or by weak base treatment of the medium. Dex treatment of hOBs was shown to induce a dose-dependent increase in the mRNA levels of cathepsin-B and -D and in the levels of cathepsin-B protein secreted by the cells. Taken together, these data suggest that Dex treatment of hOBs induces the production and secretion of lysosomal proteases that, when secreted, activate latent TGF beta which is secreted by the hOB cells. There is evidence for an involvement of more than one type of protease in this activation process. This activation of TGF beta may, therefore, play a role in glucocorticoid regulation of bone cell functions. Furthermore, TGF beta is most likely involved in autocrine and paracrine effects on bone cells.

This article has been cited by other articles:

				H. Flaster, J. Bernhagen, T. Calandra, and R. Bucala The Macrophage Migration Inhibitory Factor-Glucocorticoid Dyad: Regulation of Inflammation and Immunity Mol. Endocrinol., June 1, 2007; 21(6): 1267 - 1280. [Abstract] [Full Text] [PDF]

				K Janssens, F Vanhoenacker, M Bonduelle, L Verbruggen, L Van Maldergem, S Ralston, N Guanabens, N Migone, S Wientroub, M T Divizia, et al. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment J. Med. Genet., January 1, 2006; 43(1): 1 - 11. [Abstract] [Full Text] [PDF]

				K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]

				M.-F. Iu, H. Kaji, H. Sowa, J. Naito, T. Sugimoto, and K. Chihara Dexamethasone suppresses Smad3 pathway in osteoblastic cells J. Endocrinol., April 1, 2005; 185(1): 131 - 138. [Abstract] [Full Text] [PDF]

				P. S.N. Rowe THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 264 - 281. [Abstract] [Full Text] [PDF]

				K. R. Gantt, S. Schultz-Cherry, N. Rodriguez, S. M. B. Jeronimo, E. T. Nascimento, T. L. Goldman, T. J. Recker, M. A. Miller, and M. E. Wilson Activation of TGF-{beta} by Leishmania chagasi: Importance for Parasite Survival in Macrophages J. Immunol., March 1, 2003; 170(5): 2613 - 2620. [Abstract] [Full Text] [PDF]

				G. Fingerle-Rowson, P. Koch, R. Bikoff, X. Lin, C. N. Metz, F. S. Dhabhar, A. Meinhardt, and R. Bucala Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo Am. J. Pathol., January 1, 2003; 162(1): 47 - 56. [Abstract] [Full Text] [PDF]

				M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners Jr. Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-beta . A PROCESS INITIATED BY THE EXOCYTOSIS OF CATHEPSIN B J. Biol. Chem., April 19, 2002; 277(17): 14829 - 14837. [Abstract] [Full Text] [PDF]

				Y C G Lee, C J Devin, L R Teixeira, J T Rogers, P J Thompson, K B Lane, and R W Light Transforming growth factor {beta}2 induced pleurodesis is not inhibited by corticosteroids Thorax, August 1, 2001; 56(8): 643 - 648. [Abstract] [Full Text] [PDF]

				G. R. Beck Jr., B. Zerler, and E. Moran Gene Array Analysis of Osteoblast Differentiation Cell Growth Differ., February 1, 2001; 12(2): 61 - 83. [Abstract] [Full Text]

				S. Walsh, G. R. Jordan, C. Jefferiss, K. Stewart, and J. N. Beresford High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis Rheumatology, January 1, 2001; 40(1): 74 - 83. [Abstract] [Full Text] [PDF]

				R. C. Pereira, D. Durant, and E. Canalis Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E570 - E576. [Abstract] [Full Text] [PDF]

				K. Janssens, R. Gershoni-Baruch, E. Van Hul, R. Brik, N. Guañabens, N. Migone, L. A Verbruggen, S. H Ralston, M. Bonduelle, L. Van Maldergem, et al. Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13 J. Med. Genet., April 1, 2000; 37(4): 245 - 249. [Abstract] [Full Text]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				E. O. Abu, A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston The Localization of the Functional Glucocorticoid Receptor {alpha} in Human Bone J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 883 - 889. [Abstract] [Full Text]

				C. Binkert, M. Demetriou, B. Sukhu, M. Szweras, H. C. Tenenbaum, and J. W. Dennis Regulation of Osteogenesis by Fetuin J. Biol. Chem., October 1, 1999; 274(40): 28514 - 28520. [Abstract] [Full Text] [PDF]

				P.-E. Gleizes, J. S. Munger, I. Nunes, J. G. Harpel, R. Mazzieri, I. Noguera, and D. B. Rifkin TGF-{beta} Latency: Biological Significance and Mechanisms of Activation Stem Cells, May 1, 1997; 15(3): 190 - 197. [Abstract] [Full Text]

				M. Demetriou, C. Binkert, B. Sukhu, H. C. Tenenbaum, and J. W. Dennis Fetuin/alpha 2-HS Glycoprotein Is a Transforming Growth Factor-beta Type II Receptor Mimic and Cytokine Antagonist J. Biol. Chem., May 31, 1996; 271(22): 12755 - 12761. [Abstract] [Full Text] [PDF]